HEXCEED
LIVE

Serial Number

79265244

Owner

Genmab B.V.

Attorney

Max Vern

Filing Date

May 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HEXCEED Trademark

Serial Number: 79265244 • Registration: 6055660

HEXCEED is a trademark filed by Genmab B.V. on May 14, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Genmab B.V. (4 trademarks)

Uppsalalaan 15

Entity Type: 16

Trademark Details

Filing Date

May 14, 2019

Registration Date

May 19, 2020

Published for Opposition

March 3, 2020

Goods & Services

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases

Legal services in the field of patent exploitation; licensing of intellectual property in the field of medicine

Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals

Medical scientific and biological research, namely research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 19, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 24, 2025 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 5, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 19, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 19, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 28, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 12, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2020 TROA
REFUSAL PROCESSED BY IB
Nov 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 10, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 18, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 31, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 27, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2019 REPR